Emergent BioSolutions Announces Submission to FDA of Application Covering Emergency Use Authorization for NuThrax Pharmaceutical Investing
Green Growth Brands Announces Intention to Launch Takeover Bid for Aphria Inc. Cannabis Investing News
Spectrum Pharmaceuticals Announces Submission of Biologics License Application to the FDA for ROLONTIS Life Science Investing
Dr. Reddy’s Laboratories Announces the Launch of Sevelamer Carbonate for Oral Suspension in the U.S. Market Life Science Investing
Retrophin Doses First Patient in Pivotal Phase 3 PROTECT Study of Sparsentan for the Treatment of IgA Nephropathy Pharmaceutical Investing
